132 related articles for article (PubMed ID: 19787657)
1. Paradigm shift in the pathophysiology of postmenopausal and thyrotoxic osteoporosis.
Zaidi M; Iqbal J; Blair HC; Zallone A; Davies T; Sun L
Mt Sinai J Med; 2009 Oct; 76(5):474-83. PubMed ID: 19787657
[TBL] [Abstract][Full Text] [Related]
2. Role of the pituitary-bone axis in skeletal pathophysiology.
Imam A; Iqbal J; Blair HC; Davies TF; Huang CL; Zallone A; Zaidi M; Sun L
Curr Opin Endocrinol Diabetes Obes; 2009 Dec; 16(6):423-9. PubMed ID: 19816170
[TBL] [Abstract][Full Text] [Related]
3. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
[TBL] [Abstract][Full Text] [Related]
4. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
5. New horizons in skeletal physiology and pathophysiology.
Zaidi M; Iqbal J; Sun L
Endocr Pract; 2010; 16(5):874-81. PubMed ID: 20439235
[TBL] [Abstract][Full Text] [Related]
6. FSH and bone--important physiology or not?
Prior JC
Trends Mol Med; 2007 Jan; 13(1):1-3. PubMed ID: 17141571
[TBL] [Abstract][Full Text] [Related]
7. [Hormones and osteoporosis update. Possible roles of pituitary hormones, TSH and FSH, for bone metabolism].
Takeuchi Y
Clin Calcium; 2009 Jul; 19(7):977-83. PubMed ID: 19567994
[TBL] [Abstract][Full Text] [Related]
8. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men.
Riggs BL; Khosla S; Melton LJ
J Bone Miner Res; 1998 May; 13(5):763-73. PubMed ID: 9610739
[TBL] [Abstract][Full Text] [Related]
9. [Bone changes in thyrotoxicosis].
Ejima E; Fujiyama K; Kiriyama T; Eguchi K
Nihon Rinsho; 1998 Jun; 56(6):1587-90. PubMed ID: 9648486
[TBL] [Abstract][Full Text] [Related]
10. The long-term effect of menopause on postmenopausal bone loss in Japanese women: results from a prospective study.
Okano H; Mizunuma H; Soda M; Kagami I; Miyamoto S; Ohsawa M; Ibuki Y; Shiraki M; Suzuki T; Shibata H
J Bone Miner Res; 1998 Feb; 13(2):303-9. PubMed ID: 9495525
[TBL] [Abstract][Full Text] [Related]
11. [Control of bone remodeling by nervous system. Possible roles of pituitary hormones for bone metabolism].
Takeuchi Y
Clin Calcium; 2010 Dec; 20(12):1857-64. PubMed ID: 21123938
[TBL] [Abstract][Full Text] [Related]
12. FSH versus estrogen: who's guilty of breaking bones?
Baron R
Cell Metab; 2006 May; 3(5):302-5. PubMed ID: 16679287
[TBL] [Abstract][Full Text] [Related]
13. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis.
Pacifici R
J Bone Miner Res; 1996 Aug; 11(8):1043-51. PubMed ID: 8854239
[TBL] [Abstract][Full Text] [Related]
14. [Relation of serum growth hormone and estradiol levels and osteoporosis in postmenopausal women].
Li G; Zeng M
Zhonghua Yi Xue Za Zhi; 1990 Jan; 70(1):16-9, 2. PubMed ID: 2157532
[TBL] [Abstract][Full Text] [Related]
15. The effects of menopause and age on calcitropic hormones: a cross-sectional study of 655 healthy women aged 35 to 90.
Prince RL; Dick I; Devine A; Price RI; Gutteridge DH; Kerr D; Criddle A; Garcia-Webb P; St John A
J Bone Miner Res; 1995 Jun; 10(6):835-42. PubMed ID: 7572305
[TBL] [Abstract][Full Text] [Related]
16. [Defining the role of raloxifene as a therapeutic agent for postmenopausal osteoporosis: focus on its pharmacological properties].
Ohta H
Clin Calcium; 2004 Oct; 14(10):73-80. PubMed ID: 15577135
[TBL] [Abstract][Full Text] [Related]
17. TSH and bone loss.
Sun L; Davies TF; Blair HC; Abe E; Zaidi M
Ann N Y Acad Sci; 2006 Apr; 1068():309-18. PubMed ID: 16831931
[TBL] [Abstract][Full Text] [Related]
18. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis.
Seibel MJ; Cosman F; Shen V; Gordon S; Dempster DW; Ratcliffe A; Lindsay R
J Bone Miner Res; 1993 Jul; 8(7):881-9. PubMed ID: 8352070
[TBL] [Abstract][Full Text] [Related]
19. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
20. Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels.
Eriksen EF; Hodgson SF; Eastell R; Cedel SL; O'Fallon WM; Riggs BL
J Bone Miner Res; 1990 Apr; 5(4):311-9. PubMed ID: 2343771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
